Catalysts for Keytruda
125 tracked
Oct 16, 2023
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Oct 12, 2023
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Aug 14, 2023
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Aug 14, 2023
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Apr 3, 2023
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Mar 28, 2023
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Jan 26, 2023
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Dec 16, 2022
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Aug 5, 2022
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Jun 21, 2022
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
May 20, 2022
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Mar 21, 2022
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Feb 4, 2022
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Feb 4, 2022
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Dec 17, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Dec 3, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Nov 17, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Oct 13, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Oct 13, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Aug 31, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Aug 31, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Aug 10, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Aug 3, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Jul 26, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Jul 26, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Jul 21, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Jul 1, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Jun 28, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
May 5, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→
Mar 30, 2021
approval
KEYTRUDA (PEMBROLIZUMAB) — FDA approval
pembrolizumab
→